Adults with obesity achieved greater long-term weight loss if they partook in a nutrition plan designed for rapid weight loss ...

Dr. Amrita Ghosh explains the difference between muscle loss and fat loss. And if you drop weight too fast, it can destroy ...

Lilly’s weight loss pill gained approval in April 2026, around three months after Novo Nordisk gained the same accolade for oral Wegovy.

Semaglutide is an injectable drug formulated for the treatment of type 2 diabetes, but it’s since become increasingly popular ...

Many of the patients who tested the drug lost about 30 percent of their body weight — a loss comparable to the result of bariatric surgery ...

In a clinical trial, the new weight-loss medication retatrutide led to "clinically meaningful weight reduction," with the ...

(RTTNews) - Eli Lilly and Co. (LLY) announced that Zepbound (tirzepatide) demonstrated a significantly greater weight reduction compared to Wegovy (semaglutide) in all comparisons conducted during the ...

Worldwide, approximately half of the general population is actively attempting to lose weight. However, weight loss is typically followed by substantial weight regain, often leading to repeated cycles ...

Eli Lilly says participants in a sizable trial of retatrutide lost much more weight compared to other weight-loss drugs ...

The findings from two clinical trials suggest that a lower dose of GLP-1 drugs, or switching to an oral pill like Foundayo, ...

A low-calorie diet and behavioral support program conferred weight loss in older participants with obesity and persistent atrial fibrillation but did not significantly improve AF symptoms vs. usual ...